Aytu Biopharma Inc

詳細情報 Aytu Biopharma Inc 企業名

Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.

企業情報

企業コードAYTU

会社名Aytu Biopharma Inc

上場日Oct 20, 2017

最高経営責任者「CEO」Mr. Joshua R. (Josh) Disbrow

従業員数99

証券種類Ordinary Share

決算期末Oct 20

本社所在地7900 E. Union Avenue

都市DENVER

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号80237

電話番号17204376580

ウェブサイトhttps://aytubio.com/

企業コードAYTU

上場日Oct 20, 2017

最高経営責任者「CEO」Mr. Joshua R. (Josh) Disbrow

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jarrett T. (Josh) Disbrow

Chief Business Officer

29.46K

+130.24%

Mr. Greg Pyszczymuka

Chief Commercial Officer

23.81K

+1.79%

Mr. Ryan J. Selhorn, CPA

Chief Financial Officer, Treasurer, Corporate Secretary

16.00K

--

Mr. Carl C. Dockery

Independent Director

11.15K

--

Ms. Vivian H. Liu

Independent Director

9.82K

--

Mr. Abhinav (Abi) Jian

Independent Director

--

Mr. John A. Donofrio, Jr.

Independent Chairman of the Board

--

Mr. Joshua R. (Josh) Disbrow

Chief Executive Officer, Director

--

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jarrett T. (Josh) Disbrow

Chief Business Officer

29.46K

+130.24%

Mr. Greg Pyszczymuka

Chief Commercial Officer

23.81K

+1.79%

Mr. Ryan J. Selhorn, CPA

Chief Financial Officer, Treasurer, Corporate Secretary

16.00K

--

Mr. Carl C. Dockery

Independent Director

11.15K

--

Ms. Vivian H. Liu

Independent Director

9.82K

--

Mr. Abhinav (Abi) Jian

Independent Director

--

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

ADHD portfolio

15.39M

83.40%

Pediatric portfolio

3.06M

16.58%

Other

4.00K

0.02%

地域別USD

会社名

収益

比率

United States

18.45M

100.00%

事業別

地域別

事業別USD

会社名

収益

比率

ADHD portfolio

15.39M

83.40%

Pediatric portfolio

3.06M

16.58%

Other

4.00K

0.02%

株主

更新時刻: Sat, Jun 28

株主統計

種類

株主統計

比率

Nantahala Capital Management, LLC

12.11%

Kanen Wealth Management, LLC

6.39%

Lytton (Laurence W)

5.64%

Stonepine Capital Management, LLC

5.17%

Disbrow (Joshua R.)

1.71%

Other

68.99%

株主統計

比率

Nantahala Capital Management, LLC

12.11%

Kanen Wealth Management, LLC

6.39%

Lytton (Laurence W)

5.64%

Stonepine Capital Management, LLC

5.17%

Disbrow (Joshua R.)

1.71%

Other

68.99%

種類

株主統計

比率

Hedge Fund

14.00%

Investment Advisor/Hedge Fund

12.67%

Individual Investor

8.50%

Investment Advisor

0.65%

Other

64.18%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

67

3.22M

35.83%

+940.81K

2025Q1

66

2.05M

28.89%

-146.84K

2024Q4

71

2.05M

33.28%

-280.21K

2024Q3

75

2.20M

40.58%

-328.29K

2024Q2

78

2.26M

43.50%

-3.54K

2024Q1

82

1.99M

41.33%

-356.06K

2023Q4

85

1.96M

40.81%

-395.45K

2023Q3

91

1.92M

40.24%

-406.76K

2023Q2

100

1.89M

40.00%

+821.00K

2023Q1

134

705.12K

28.77%

-175.85K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Nantahala Capital Management, LLC

1.09M

12.11%

--

Jun 06, 2025

Kanen Wealth Management, LLC

573.36K

6.39%

+407.09K

+244.84%

Jun 26, 2025

Lytton (Laurence W)

506.61K

5.64%

+506.61K

--

Jun 09, 2025

Stonepine Capital Management, LLC

463.72K

5.17%

+56.17K

+13.78%

Mar 31, 2025

Disbrow (Joshua R.)

153.26K

1.71%

+66.67K

+76.99%

Jun 09, 2025

Renaissance Technologies LLC

76.82K

0.86%

+1.40K

+1.86%

Mar 31, 2025

Armistice Capital LLC

57.60K

0.64%

-92.40K

-61.60%

Mar 31, 2025

Geode Capital Management, L.L.C.

53.94K

0.6%

+11.21K

+26.23%

Mar 31, 2025

Citadel Advisors LLC

30.49K

0.34%

+19.43K

+175.66%

Mar 31, 2025

Disbrow (Jarrett T)

29.46K

0.33%

+16.67K

+130.24%

Jun 09, 2025

詳細を見る

2.640USD

Aytu Biopharma Inc

2.640

概要

企業名

金融